FIELD: medicine.
SUBSTANCE: invention relates to use of NADP-oxidase inhibitors. Application of NADP-oxidase inhibitors as medicinal agent for normalization of female reproductive system cell metabolism in treatment of endometriosis.
EFFECT: use of the invention provides higher therapeutic effectiveness and reduced probability of recurrences due to normalization of metabolism of pathological cells involved in the development of endometriosis.
1 cl, 7 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROTECTING NEURONS IN NEURODEGENERATIVE DISEASES AND APPARATUS FOR IMPLEMENTATION THEREOF | 2021 |
|
RU2783111C1 |
| METHOD FOR CREATING CELL MODEL OF PREMATURE OVARIAN FAILURE IN WISTAR RATS | 2023 |
|
RU2815539C1 |
| DEVICE FOR FLUORESCENT-REFLECTIVE SPECTROSCOPY FOR DIAGNOSING FOCAL AND DIFFUSE NEW GROWTHS IN A FINE-NEEDLE PUNCTURE-ASPIRATION BIOPSY | 2018 |
|
RU2709830C1 |
| METHOD FOR PREDICTION OF PREGNANCY RATE THROUGH IN VITRO FERTILISATION WITH SELECTIVE EMBRYO TRANSFER BY REAL-TIME PCR EVALUATION OF MOLECULAR GENETIC GAMETE PROFILE | 2014 |
|
RU2550965C1 |
| DEVICE FOR OPTICAL DIAGNOSTICS OF BLOOD SUPPLY AND LIFE SUPPORT OF BIO-TISSUES | 2017 |
|
RU2663938C1 |
| METHOD OF INCREASING THE EFFICIENCY OF PROTON THERAPY ON MELANOMA STEM CELLS | 2022 |
|
RU2798733C2 |
| AMIDE OF NONAPEPTIDE PREVENTING INCREASE OF HYPERPERMEABILITY OF VESSEL ENDOTHELIUM | 2012 |
|
RU2493164C1 |
| USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
| METHOD FOR DIAGNOSIS OF MICROCIRCULATORY AND TISSUE DISORDERS IN FEET OF PATIENTS WITH DIABETES MELLITUS | 2017 |
|
RU2688811C2 |
| AMINO-ACID DERIVATIVE OF THE DECAHYDRO-CLOSO-DECABORATE ANION AND ITS ANTIVIRAL ACTIVITY AGAINST INFLUENZA A VIRUS | 2020 |
|
RU2749006C1 |
